Back to search
Anticholinergic Toxicity
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Anticholinergic Toxicity trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Anticholinergic Toxicity trials you may qualify forThis study aims to evaluate the clinical efficacy of rivastigmine in reversing the full spectrum of toxic anticholinergic delirium, with a specific focus on hyp…
Antimuscarinic delirium (AMD) is a common and dangerous toxicology condition caused by poisoning by medications and other chemicals that block muscarinic recept…
Malnutrition leads to poor clinical outcomes in dementia patients. The investigator aimed to examine the association between drug burden index (DBI) and anticho…